Jackob Moskovitz

Jackob Moskovitz

Mar 17, 2019

Group 6 Copy 159
0
    Please wait...

    About This Project

    Oxidized forms of the peptide beta-amyloid (Aβ) are considered to be toxic to the brain, leading to the development of Alzheimer's disease (AD). Based on our preliminary data, we hypothesize that an immunization of an AD-model mice with a recombinant protein enriched with the oxidized amino acid methionine sulfoxide will cause the removal of toxic Aβ from brain. Consequently, this treatment is expected to inhibit the development of AD and alleviate cognitive impairment.

    More Lab Notes From This Project

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    How does taking Ritalin affect depersonalization-derealization disorder patients?

    We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...

    Synthesis of a Kidney Cancer Drug

    We need to prepare a 75 mg sample of our anti-kidney cancer drug for testing. The sample was requested by...

    Early-Stage Drug Discovery for Chagas' Disease

    An estimated 6 – 7 million people in Latin America and 300,000 U.S. citizens are infected with the protozoan...

    Campaign Ended

    A medicine project funded by 45 people